Financial Performance - Operating revenue for the period was ¥382,585,206.31, representing a significant increase of 149.05% year-on-year[4] - Net profit attributable to shareholders was ¥96,992,749.11, a turnaround from a loss of ¥24,855,428.82 in the same period last year[4] - Basic earnings per share for the period was ¥0.55, compared to a loss of ¥0.14 per share in the previous year[4] - The company reported a total of ¥3,984,796.31 in non-recurring gains and losses for the period[5] - The company achieved operating revenue of RMB 382.59 million, an increase of RMB 228.97 million or 149.05% compared to the same period last year[11] - The net profit attributable to shareholders was RMB 96.99 million, a turnaround from a loss of RMB 24.86 million in the same period last year[12] - Total operating revenue for Q1 2021 reached RMB 382,585,206.31, a significant increase from RMB 153,614,830.20 in Q1 2020, representing a growth of 149.5%[20] - Net profit for Q1 2021 was RMB 99,315,085.73, compared to a net loss of RMB 28,408,114.30 in Q1 2020, indicating a turnaround in profitability[20] - The company reported a basic earnings per share of RMB 0.55 for Q1 2021, compared to a loss per share of RMB -0.14 in Q1 2020[21] - Total comprehensive income for Q1 2021 was RMB 120,373,389.52, a significant recovery from a loss of RMB -80,366,877.89 in Q1 2020[21] Cash Flow - Net cash flow from operating activities was ¥15,609,445.06, a significant improvement from a negative cash flow of ¥54,461,823.95 in the same period last year[4] - Cash flow from operating activities totaled RMB 375,765,049.92 in Q1 2021, compared to RMB 270,287,164.05 in Q1 2020, showing improved cash generation[24] - In Q1 2021, the net cash flow from operating activities was -30,284,718.27, compared to -28,836,899.02 in Q1 2020, indicating a decline in operational cash flow[26] - The total cash inflow from investment activities was 68,757,274.04, up from 32,979,522.42 in the same period last year, reflecting an increase in investment returns[26] - The net cash flow from investment activities was -190,312,463.07, significantly worse than -43,738,637.18 in Q1 2020, highlighting increased investment expenditures[26] - The total cash flow for the period showed a net decrease of -222,592,297.29, compared to -72,714,182.45 in Q1 2020, reflecting overall financial strain[26] Assets and Liabilities - Total assets at the end of the reporting period reached ¥6,402,802,145.37, an increase of 1.65% compared to the end of the previous year[4] - Current assets totaled ¥3,770,803,864.17, slightly down from ¥3,809,958,571.16 at the end of 2020, indicating a decrease of about 1.02%[16] - Non-current assets increased to ¥2,631,998,281.20 from ¥2,488,746,817.00, reflecting a growth of approximately 5.73%[16] - Total liabilities decreased to ¥547,186,310.43 from ¥564,462,942.74, showing a reduction of approximately 3.06%[17] - Shareholders' equity increased to ¥5,855,615,834.94 from ¥5,734,242,445.42, representing a growth of about 2.11%[17] - The company reported an increase in accounts receivable to ¥365,695,416.59 from ¥333,527,490.76, which is an increase of approximately 9.63%[16] - Inventory levels rose slightly to ¥258,395,227.48 from ¥255,126,944.53, indicating a growth of about 0.89%[16] Research and Development - Research and development expenses accounted for 9.55% of operating revenue, a decrease of 8.91 percentage points from the previous year[4] - Research and development expenses amounted to RMB 36.53 million, representing a growth of 28.82% year-on-year[13] - Research and development expenses increased to RMB 36,527,079.45 in Q1 2021, up from RMB 28,354,664.31 in Q1 2020, reflecting a focus on innovation[20] Shareholder Information - The company had a total of 7,411 shareholders at the end of the reporting period[6] - The top shareholder, Jiang Wei, held 25.17% of the shares, totaling 44,449,000 shares[6] Other Financial Metrics - The weighted average return on equity was 1.75%, compared to -0.46% in the previous year[4] - The company reported a significant decrease in other income by 52.45% to RMB 4.75 million, attributed to reduced government subsidies compared to the previous year[11] - The company recorded investment income of RMB 13,750,368.57 in Q1 2021, a significant increase from RMB 3,351,610.11 in Q1 2020, indicating better investment performance[20] - Sales expenses rose to RMB 122,111,278.28 in Q1 2021, compared to RMB 114,868,235.77 in Q1 2020, indicating increased investment in sales efforts[20] - The company reported a total operating cost of RMB 284,719,567.04 in Q1 2021, up from RMB 193,029,975.02 in Q1 2020, reflecting higher operational expenses[20]
昊海生科(688366) - 2021 Q1 - 季度财报